by Adrianna MacPherson, University of Alberta Credit: CC0 Public Domain New research shows a group of enzymes may have a critical role in the process of how immune cells are activated and then migrate to certain sites in the body—findings that could improve our understanding of inflammation and potentially lead to new treatments. In a...
Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before
JUNE 20, 2022 by Jocelyn Solis-Moreira People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California San Diego. In fact, scientists say most coronavirus long-haulers battle brain-related issues. The findings are part of a long-term study tracking the progression of neurological symptoms...
CLUES TO LONG COVID Scientists strive to unravel what is driving disabling symptoms
They span three continents, but a trio of researchers who’ve never met share a singular focus made vital by the still-raging pandemic: deciphering the causes of Long Covid and figuring out how to treat it. Almost 2 years ago in Italy, pediatric infectious disease doctor Danilo Buonsenso, who works at Gemelli University Hospital, started to...
New model helps identify mutations that drive cancer
Anne Trafton | MIT News Office Publication Date: June 20, 2022 Caption: An MIT-led team has built a new system that rapidly scans the genome of cancer cells, could help researchers find targets for new drugs. Credits: Image: Dylan Burnette and Jennifer Lippincott-Schwartz, National Institutes of Health, edited by MIT News Cancer cells can have...
This May Be the COVID Variant Scientists Are Dreading
David Axe Published Jun. 20, 2022 3:20AM ET Photo Illustration by Thomas Levinson/The Daily Beast/Getty COVID-19 cases are increasing again in the United Kingdom, potentially signaling a future surge in infections in the United States and other countries. A pair of new subvariants of the dominant Omicron variant—BA.4 and BA.5—appear to be driving the uptick in cases...
Have trouble grinding your teeth? Here’s how to control it
By Sally Wadyka June 20, 2022 at 2:00 p.m. EDT Dentists reported a 69 percent jump in patients who clench or grind their teeth during the pandemic, according to the American Dental Association (ADA). And most of these people are probably unaware that they’re doing it. “It’s an almost completely unconscious behavior,” says Vicki Cohn,...
Scientists Created a ‘Self-Plugging’ Eye Microneedle, And It’s as Creepy as It Sounds
JACINTA BOWLER 20 JUNE 2022 This might sound like the stuff of horror movies, but to treat some diseases you need to have drugs carefully injected into your eye. Not only does the process sound terrible, there’s actually quite a few things that could go wrong. For example, there’s endophthalmitis – which is a bacterial...
America’s first CRISPR trial is still nearly 100% effective 3 years on
By Rich Haridy June 19, 2022 The new data reports nearly 100 percent success in 75 patients treated with efficacy persisting up to three years beyond the initial treatment Depositphotos Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up...
BONE LOSS MEDS MAY LOWER OVARIAN CANCER RISK
Researchers compared medications taken by more than 50,000 women over the age of 50, using de-identified medical records from 2004–2013, to analyze differences in those with ovarian cancer and those without. Women who used nitrogen-based bisphosphonates were found to be less likely to develop ovarian cancer, says Karen Tuesley, a PhD candidate at the University of Queensland...
New screening technology could increase the number of cancer tests done on a solid tumor by 50 times
by University of Strathclyde, Glasgow Microfluidic tumor-stromal co-culture for CAR-T studies. (A) Image of the OC3D Single microfluidic device used (ScreenIn3D Ltd, U.K.) with schematic showing principle of cell seeding. A single-cell suspension flows through a microchannel and cells sediment into microwell traps below the microchannel level. Scale bar = 10 mm. (B) Brightfield and fluorescence images...